EvolutionaryScale vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (82 vs 55)
EvolutionaryScale logo

EvolutionaryScale

ChallengerHealthcare & Life Sciences

AI Protein Design & Biology

AI biology lab building protein design models (ESM3, 98B params). Founded 2023 by ex-Meta scientists. $142M seed. Acquired by Chan Zuckerberg Biohub Nov 2025.

AI VisibilityBeta
Overall Score
C55
Category Rank
#170 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
53
Perplexity
61
Gemini
57

About

EvolutionaryScale was an AI research lab founded in 2023 by former Meta AI protein team scientists, including CEO Alexander Rives. Based in New York City, the company developed frontier AI models for protein design and biological discovery. Its flagship model ESM3 is a 98-billion-parameter generative AI system trained on 2.78 billion protein sequences capable of reasoning over protein sequence, structure, and function simultaneously.

Full profile
AbbVie logo

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A82
Category Rank
#14 of 596
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
87
Perplexity
82
Gemini
86

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

55
Overall Score
82
#170
Category Rank
#14
72
AI Consensus
87
stable
Trend
stable
53
ChatGPT
87
61
Perplexity
82
57
Gemini
86
49
Claude
87
57
Grok
84

Key Details

Category
AI Protein Design & Biology
General
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only EvolutionaryScale
AI Protein Design & Biology

Integrations

Only AbbVie
AbbVie is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.